CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV)
CUSIP: 18914F103
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 416,598,522
- Total 13F shares
- 135,271,235
- Share change
- -11,040,595
- Total reported value
- $413,882,154
- Put/Call ratio
- 46%
- Price per share
- $3.06
- Number of holders
- 199
- Value change
- -$32,444,876
- Number of buys
- 86
- Number of sells
- 87
Quarterly Holders Quick Answers
What is CUSIP 18914F103?
CUSIP 18914F103 identifies CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 18914F103:
Top shareholders of CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
|
Company |
7.2%
from 13D/G
|
30,396,991
|
$84,807,604 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.8%
|
24,246,034
|
$67,646,435 | — | 30 Jun 2025 | |
| Chamath Palihapitiya |
3/4/5
|
FORMER CHIEF EXECUTIVE OFFICER AND DIRECTOR, 10%+ Owner |
—
class O/S missing
|
30,147,610
|
$29,544,657 | — | 07 Jul 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
2.5%
|
10,493,600
|
$29,277,144 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.4%
|
9,843,349
|
$27,466,720 | — | 30 Jun 2025 | |
| GREENOAKS CAPITAL PARTNERS LLC |
3/4/5
|
Other*, 10%+ Owner |
—
class O/S missing
|
25,754,556
|
$24,466,828 | — | 22 Nov 2021 | |
| STATE STREET CORP |
13F
|
Company |
1.8%
|
7,507,390
|
$20,945,618 | — | 30 Jun 2025 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
1.1%
|
4,463,811
|
$12,454,033 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.96%
|
4,012,744
|
$11,195,555 | — | 30 Jun 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.93%
|
3,893,910
|
$10,864,009 | — | 30 Jun 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.85%
|
3,530,371
|
$9,849,735 | — | 30 Jun 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.85%
|
3,523,047
|
$9,829,302 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.82%
|
3,398,171
|
$9,480,898 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.81%
|
3,376,011
|
$9,419,070 | — | 30 Jun 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.72%
|
2,991,753
|
$8,346,991 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.57%
|
2,361,184
|
$6,587,703 | — | 30 Jun 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.51%
|
2,115,002
|
$5,900,856 | — | 30 Jun 2025 | |
| Scott J. Leffler |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
4,857,303
|
$4,760,157 | — | 25 Jan 2024 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.36%
|
1,487,158
|
$4,149,170 | — | 30 Jun 2025 | |
| Aric R. Sharp |
3/4/5
|
CEO of Value Based Care |
—
class O/S missing
|
2,100,665
|
$3,907,237 | — | 09 Aug 2024 | |
| GMT CAPITAL CORP |
13F
|
Company |
0.31%
|
1,305,200
|
$3,641,508 | — | 30 Jun 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.28%
|
1,173,133
|
$3,273,042 | — | 30 Jun 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.27%
|
1,119,013
|
$3,122,047 | — | 30 Jun 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.26%
|
1,101,809
|
$3,074,047 | — | 30 Jun 2025 | |
| CLOVER HEALTH INVESTMENTS, CORP. /DE |
3/4/5
|
Chief Technology Officer |
—
class O/S missing
|
3,093,225
|
$3,031,361 | — | 31 Oct 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.25%
|
1,058,215
|
$2,952,420 | — | 30 Jun 2025 | |
| Joseph R. Martin |
3/4/5
|
General Counsel |
—
class O/S missing
|
2,718,857
|
$2,664,480 | — | 14 Jun 2023 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.23%
|
954,848
|
$2,664,026 | — | 30 Jun 2025 | |
| JUPITER ASSET MANAGEMENT LTD |
13F
|
Company |
0.23%
|
939,590
|
$2,621,456 | — | 30 Jun 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.22%
|
906,338
|
$2,528,683 | — | 30 Jun 2025 | |
| Soviero Asset Management, LP |
13F
|
Company |
0.22%
|
900,000
|
$2,511,000 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.21%
|
893,352
|
$2,492,452 | — | 30 Jun 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.19%
|
800,674
|
$2,233,880 | — | 30 Jun 2025 | |
| Swiss National Bank |
13F
|
Company |
0.18%
|
758,500
|
$2,116,215 | — | 30 Jun 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.17%
|
714,891
|
$1,994,250 | — | 30 Jun 2025 | |
| Chelsea Clinton |
3/4/5
|
Director |
—
class O/S missing
|
602,814
|
$1,983,258 | — | 06 Jan 2025 | |
| Lee Shapiro |
3/4/5
|
Director |
—
class O/S missing
|
598,622
|
$1,969,466 | — | 06 Jan 2025 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.15%
|
645,432
|
$1,800,755 | — | 30 Jun 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.15%
|
644,723
|
$1,798,777 | — | 30 Jun 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.15%
|
633,700
|
$1,768,023 | — | 30 Jun 2025 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.15%
|
610,619
|
$1,703,627 | — | 30 Jun 2025 | |
| TEACHER RETIREMENT SYSTEM OF TEXAS |
13F
|
Company |
0.14%
|
597,300
|
$1,666,467 | — | 30 Jun 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.14%
|
584,459
|
$1,630,629 | — | 30 Jun 2025 | |
| IMC-Chicago, LLC |
13F
|
Company |
0.12%
|
484,641
|
$1,352,148 | — | 30 Jun 2025 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.12%
|
483,803
|
$1,349,810 | — | 30 Jun 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.11%
|
473,875
|
$1,322,111 | — | 30 Jun 2025 | |
| Nathaniel S. Turner |
3/4/5
|
Director |
—
class O/S missing
|
1,324,728
|
$1,258,492 | — | 07 Jan 2021 | |
| Legal & General Group Plc |
13F
|
Company |
0.11%
|
437,681
|
$1,221,130 | — | 30 Jun 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.1%
|
410,900
|
$1,146,411 | — | 30 Jun 2025 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.09%
|
395,421
|
$1,103,000 | — | 30 Jun 2025 |
Institutional Holders of CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) as of Q3 2025
As of 30 Sep 2025,
CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) was held by
199 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
135,271,235 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, PNC Financial Services Group, Inc., CHARLES SCHWAB INVESTMENT MANAGEMENT INC, NORTHERN TRUST CORP, Divisadero Street Capital Management, LP, and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
200
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
197
Q3 2025 holders
199
Holder diff
2
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.